By stratifying pan-cancer patients into HRG and LRG according to their respective ChemoScores, we observed an overall trend, wherein tumour progression was more inclined to occur in high-risk patients, whilst low-risk patients exhibited extended survival periods.
← all excerpts
Neutrophil chemotaxis score and chemotaxis-related genes have the potential for clinical application to prognosticate the survival of patients with tumours.
1
—
—